Placement peripherally inserted central catheters (PICC): the upper arm approach
Creators
- 1. Samsung Medical Center, Seoul (Korea, Republic of)
- 2. Mayo Clinic, Lansing (United States)
- 3. University of Michigan Hospital, Lansing (United States)
Description
To evaluate a recently developed technique to place a medium-duration (weeks to months) central venous access. Within three-year period, 635 patients were referred to interventional radiology suite for placement of peripherally inserted central catheter (PICC). Contrast medium was injected into the peripheral intravenous line and a puncture was made into the opacified vein near the junction of the middle and upper thirds of the upper arm, either the brachial or basilic vein under fluoroscopic guidance. A 5.5-French peel-away sheath was inserted into the vein and a 5-French silicone catheter was introduced with its distal tip to the junction of the right atrium and superior vena cava. Catheter placement was successful in all patients unless there was a central venous obstruction. Catheters were maintained from 2 days to 5 months with a mean of 3 weeks. Complications included infection requiring removal of the PICC in 16 patients (2.5%), acute thrombosis of the subclavian vein in 3 (0.5%). Occluded catheters in 4 patients were easily cleared with urokinase in place. The PICC system is an excellent option for medium-duration central venous access. Patients were able to carry on normal activities with the catheters in place
Additional details
Publishing Information
- Journal Title
- Journal of the Korean Radiological Society
- Journal Volume
- 33
- Journal Issue
- 6
- Series
- 18 refs, 2 figs
- Journal Page Range
- p. 861-864
- ISSN
- 0301-2867
INIS
- Country of Publication
- Korea, Republic of
- Country of Input or Organization
- Korea, Republic of
- INIS RN
- 38091675
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- ARMS; INFECTIVITY; PATIENTS; THROMBOSIS; UROKINASE; VEINS
- Descriptors DEC
- BLOOD COAGULATION FACTORS; BLOOD VESSELS; BODY; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; DISEASES; DRUGS; ENZYMES; FIBRINOLYTIC AGENTS; HEMATOLOGIC AGENTS; HYDROLASES; LIMBS; NONSPECIFIC PEPTIDASES; ORGANIC COMPOUNDS; ORGANS; PEPTIDE HYDROLASES; PROTEINS; VASCULAR DISEASES